6 hrs ago
Genomic Health Receives Average Recommendation of "Hold" from Analysts
Genomic Health has received a consensus rating of "Hold" from the ten brokerages that are covering the stock, American Banking and Market News reports .
Tue Aug 19, 2014
New England BiolabsA Introduces New Ribosomal RNA Depletion Technology from Genomic Health
New England Biolabs, Inc. ) today announced that NEB has exclusively in-licensed rights from Genomic Health, Inc. to its technology for the depletion of abundant RNAs, which is instrumental to performing sensitive RNA-seq experiments at a lower cost.
Sun Aug 17, 2014
Genomic Health EVP Steven Shak Unloads 13,348 Shares
Genomic Health EVP Steven Shak unloaded 13,348 shares of the stock in a transaction dated Thursday, August 14th.
Fri Aug 15, 2014
Insider Selling: Steven Shak Sells 13,348 Shares of Genomic Health Stock
Genomic Health EVP Steven Shak unloaded 13,348 shares of Genomic Health stock on the open market in a transaction that occurred on Thursday, August 14th.
Mon Aug 11, 2014
Genomic Health Rating Reiterated by Canaccord Genuity
's stock had its "hold" rating restated by equities research analysts at Canaccord Genuity in a research note issued to investors on Monday.
Fri Aug 08, 2014
Genomic Health to Present at the Canaccord Genuity 34th Annual Growth Conference
Genomic Health, Inc. today announced that Brad Cole , Chief Operating Officer and Chief Financial Officer, will present at the 34 Annual Canaccord Growth Conference in Boston on Wednesday, August 13 at 10:30 a.m. Eastern Time .
Thu Aug 07, 2014
Genomic Health's (GHDX) CEO Kimberly Popovits on Q2 2014 Results - Earnings Call Transcript
G. Bradley Cole - Chief Financial Officer, Chief Operating Officer, Principal Accounting Officer, Secretary and Member of Non-Management Stock Option Committee Good afternoon.
Wed Aug 06, 2014
Genomic Health Announces Positive Topline Results of Additional,...
This study validated the Oncotype DX prostate cancer test as a predictor of biochemical recurrence, a rise in prostate-specific antigen following surgery, which is a measure of longer-term outcomes for aggressive disease.
Mon Aug 04, 2014
Genomic Health (GHDX) to Release Quarterly Earnings on Tuesday
Genomic Health will be issuing its Q214 quarterly earnings data on Tuesday, August 5th.
Thu Jul 31, 2014
Genomic Health to Announce Second Quarter 2014 Financial Results and...
Genomic Health, Inc. today announced that the company will host a conference call and webcast on Thursday, August 7 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results.